Application no. and date | 01939267.9 (espacenet) (Federated) (European Patent Register), 20010522 | Patent/reg. no. and date | DK/EP 1296951, 20101006 | Publication date | 20030402 | Priority no. and date | US 208017 P, 20000526 | EP pub. no. and date |
EP 1296951 20030402 | Effective date | | Applicant/owner | Merck Sharp & Dohme Corp., 126 East Lincoln Avenue
Rahway, NJ 07065, US | Applicant ref. no. | 10202-4 | Inventor | DAVIES, Ian, W., 126 East Lincoln Avenue
Rahway, NJ 07065-0907, US, KOTLIAR, Andrew, 126 East Lincoln Avenue
Rahway, NJ 07065-0907, US, CROCKER, Louis, S., 126 East Lincoln Avenue
Rahway, NJ 07065-0907, US, OSIFCHIN, Richard, G., 126 East Lincoln Avenue
Rahway, NJ 07065-0907, US | Representative | Marks & Clerk LLP, 44 rue de la Vallée
BP 1775
L-1017 Luxembourg, LU | Opponent | | IPC Class | A61K 31/444 (2006.01) , A61P 29/00 (2006.01) , C07D 213/61 (2006.01) | Title | 5-chloro-3-(4-methansulfonylphenyl)-6'-methyl-[2,3']bipyridinyl i ren krystallinsk form og synteseproces | Int. application no. | US2001016566 | Int. publication no. | WO2001092230 | Related patent (certificate) | | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|